Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Merlino, L. A.
Right arrow Articles by Saag, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merlino, L. A.
Right arrow Articles by Saag, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Preferences for Fractures and Other Glucocorticoid-Associated Adverse Effects among Rheumatoid Arthritis Patients

Linda A. Merlino, MSc

Department of Internal Medicine, University of Iowa, Iowa City

Indranil Bagchi, PhD

Smith Kline Beecham & Co., Collegeville, Pennsylvania

Thomas N. Taylor, PhD

Parke-Davis & Co., Ann Arbor, Michigan

Paul Utrie, MD

Department of Internal Medicine, University of Iowa, Iowa City

Elizabeth Chrischilles, PhD

Department of Epidemiology, University of Iowa, Iowa City

Walton Sumner, II, MD

Division of General Medical Sciences, Washington University, St. Louis, Missouri

Amy Mudano, MPH

Department of Medicine and Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, University of Alabama at Birmingham

Kenneth G. Saag, MD, MSc

Department of Medicine and Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, University of Alabama at Birmingham

Objective. The objective of this study was to determine rheumatoid arthritis (RA) patients’ preferences for validated health state scenarios depicting glucocorticoid adverse events, predictors of these preferences, and psychometric properties of different preference techniques in this population. Methods. Preferences were elicited by rating scale and time trade-off methods. Time trade-offs included trading current health for either time spent alive in an adverse health state for chronic conditions (time trade-off) or time spent in a sleeplike state for acute conditions (sleep trade-off). Results. A total of 107 subjects with long-standing RA participated in the preference interviews. Mean preference values (rating scale/trade-off) were lowest for serious fracture adverse events, including hip fracture requiring a nursing home stay (0.55 ± 0.22/0.76 ± 0.36) and vertebral fracture with chronic pain (0.59 ± 0.23/0.67 ± 0.35), and highest for cataracts (0.84 ± 0.17/0.96 ± 0.09) and wrist fracture (0.82 ± 0.18/0.81 ± 0.29). Rating scales had a stronger correlation (r= 0.88) with physician ranking of scenarios than trade-off methods (r = 0.31). All methods were feasible and demonstrated good reliability, while rating scale method showed better construct validity than trade-off techniques. Conclusion. Relative to their current health, RA patients assigned low preference values to many glucocorticoid adverse events, particularly those associated with chronic fracture outcomes. Results varied with the preference measure used, indicating that methodological attributes of preference determinations must be considered in clinical decision making.

Key Words: preference measurement • time trade-off • rheumatoid arthritis • glucocorticoids • osteoporosis • health-related quality of life

Medical Decision Making, Vol. 21, No. 2, 122-132 (2001)
DOI: 10.1177/0272989X0102100205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
J N Hoes, J W G Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, E H Choy, M Cutolo, J A P Da Silva, G Esselens, et al.
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Ann Rheum Dis, December 1, 2007; 66(12): 1560 - 1567.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
M. Locadia, P. F. M. Stalmeier, F. J. Oort, M. H. Prins, M. A. G. Sprangers, and P. M. M. Bossuyt
A Comparison of 3 Valuation Methods for Temporary Health States in Patients Treated with Oral Anticoagulants
Med Decis Making, November 1, 2004; 24(6): 625 - 633.
[Abstract] [PDF]